Reposted by Caleb Cheng
In a recent Nature paper, @djcalebc.bsky.social et al. explore how PIKfyve regulates lysosomal lipid recycling in PDAC. This opens up a therapeutic window: co-inhibition of PIKfyve and the KRAS–MAPK pathway leads to synthetic lethality & tumor regression.
View it here >>> nature.com/articles/s41...